A detailed history of Bank Of America Corp transactions in Organon & Co. stock. As of the latest transaction made, Bank Of America Corp holds 1,309,915 shares of OGN stock, worth $20.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,309,915
Previous 1,204,680 8.74%
Holding current value
$20.7 Million
Previous $22.6 Million 19.73%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $1.84 Million - $2.31 Million
105,235 Added 8.74%
1,309,915 $27.1 Million
Q1 2024

May 15, 2024

BUY
$13.78 - $18.8 $5.46 Million - $7.45 Million
396,139 Added 48.99%
1,204,680 $22.6 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $2.4 Million - $3.79 Million
-218,931 Reduced 21.31%
808,541 $11.7 Million
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $7.22 Million - $9.23 Million
-374,634 Reduced 26.72%
1,027,472 $21.4 Million
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $9.12 Million - $13.7 Million
425,764 Added 43.61%
1,402,106 $33 Million
Q4 2022

Feb 10, 2023

SELL
$23.31 - $28.61 $7.21 Million - $8.85 Million
-309,185 Reduced 24.05%
976,342 $27.3 Million
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $4.23 Million - $6.19 Million
-180,779 Reduced 12.33%
1,285,527 $30.1 Million
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $2.06 Million - $2.53 Million
-64,980 Reduced 4.24%
1,466,306 $49.5 Million
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $11.9 Million - $15.4 Million
-390,934 Reduced 20.34%
1,531,286 $53.5 Million
Q4 2021

Feb 08, 2022

SELL
$28.67 - $37.13 $7.31 Million - $9.47 Million
-255,015 Reduced 11.71%
1,922,220 $58.5 Million
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $9.87 Million - $12.3 Million
-344,908 Reduced 13.68%
2,177,235 $71.4 Million
Q2 2021

Sep 13, 2021

BUY
$28.45 - $38.0 $71.8 Million - $95.8 Million
2,522,143 New
2,522,143 $76.3 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $4.02B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.